金石亚药 (300434)
Sichuan Goldstone Asia Pharmaceutical Inc.
K-Line Chart
No K-line data available
Company NameSichuan Jinshi Yazhou Pharmaceutical Co., Ltd.
Listing Date2015-04-24
Issue Price10.57RMB
Registered Capital40174.387210k RMB
Legal RepresentativeMa Yiping
Registered AddressWanjia Community, Jiujiang Town, Shuangliu District, Chengdu City, Sichuan Province
IndustryChemical Pharmaceuticals
Main BusinessSpecialized Equipment Technology R&D and Manufacturing, and Pharmaceutical Health
Company ProfileJinshi Oriental is dedicated to the research, development, and application of steel-reinforced plastic composite pipe technology and vacuum coating technology. It provides customers with steel-reinforced plastic composite pipes, complete production processes for vacuum coating, technical solutions, and complete sets of production equipment. The company integrates five functions: solution design, product manufacturing, production and sales, installation and commissioning, and after-sales service. Currently, it is a National High-Tech Enterprise, a Sichuan Provincial Enterprise Technology Center, a member of the Plastic Pipe Committee of the China Plastics Processing Industry Association, and a council member of 'Special Structures'. It has been awarded the 'Outstanding Contribution' award jointly issued by the Ministry of Construction's Science and Technology Promotion Center and the Plastic Pipe Expert Group of the China Chemical Building Materials Coordination Group.
Stock Details
1. Key Indicators
- Total Shares(W): 40174.39
- Circulating A-Shares(W): 34212.11
- Earnings Per Share(RMB): 0.2400
- Net Assets Per Share(RMB): 6.2653
- Operating Revenue(W RMB): 70844.55
- Total Profit(W RMB): 11241.18
- Net Profit Attributable to Parent(W RMB): 9676.59
- Net Profit Growth Rate(%): 66.47
- Weighted Return on Equity(%): 3.8900
- Operating Cash Flow Per Share(RMB): 0.3770
- Undistributed Profit Per Share(RMB): 0.6378
- Capital Reserve Per Share(RMB): 4.4488
2. Main Business
The main business covers:
- R&D, production, and sales of over-the-counter (OTC) drugs
- R&D, production, and sales of prescription drugs
- R&D, production, and sales of active pharmaceutical ingredients (APIs)
- R&D, production, and sales of health foods
3. Company Basic Information
- Company Name: Sichuan Goldstone Asia Pharmaceutical Inc.
- Listing Date: 2015-04-24
- Industry: Pharmaceutical Manufacturing
- Address: 8F, Block A1, Dadi Xinguanghua Plaza, No.8 Jiayuan Road, Qingyang District, Chengdu, Sichuan; Yake Center, No.4760 Jiangnan Avenue, Binjiang District, Hangzhou, Zhejiang
- Website: www.goldstone-group.com
- Company Profile: The company was formerly known as Sichuan Goldstone Oriental New Materials & Equipment Co., Ltd. and was restructured into a joint-stock company in 2011. The company is primarily engaged in the R&D, production, and sales of over-the-counter drugs, prescription drugs, active pharmaceutical ingredients, and health foods.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Dier Investment Co., Ltd. | General Legal Person | 1456.44 | 4.26 |
| 2 | Hainan Yadongnan Industry and Trade Co., Ltd. | General Legal Person | 815.55 | 2.38 |
| 3 | Shanghai Tongyi Investment Management Co., Ltd. - Tongyi Furong No.19 Private Securities Investment Fund | Private Securities Investment Fund | 167.52 | 0.49 |
5. Concept Sectors
- Energy Conservation & Environmental Protection
- Infant & Child Concept
- Vitamins
- PPP Concept
- Underground Pipeline Network
- CXO Concept
- Innovative Drugs
- Small Cap Non-Marginable
- Private Placement New Entry
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information